Clinical Outcomes in Adult Patients Receiving Definitive Cefazolin Therapy for Community-Acquired Enterobacterales Bacteremias across Minimum Inhibitory Concentration Breakpoints.
Saved in:
| Title: | Clinical Outcomes in Adult Patients Receiving Definitive Cefazolin Therapy for Community-Acquired Enterobacterales Bacteremias across Minimum Inhibitory Concentration Breakpoints. |
|---|---|
| Authors: | Lam J; PharmD, ACPR, RPh, is with North York General Hospital, Toronto, Ontario., Forrest RO; BSc, MSc, is with the Division of Epidemiology and the Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario., Li X; MD, FRCPC, is with North York General Hospital, the Shared Hospital Laboratory, and the Department of Microbiology, Sunnybrook Health Sciences Centre, Toronto, Ontario., Das P; MD, is with North York General Hospital, Toronto, Ontario., Kan T; PharmD, RPh, is with North York General Hospital, Toronto, Ontario., Raybardhan S; BScPhm, MPH, ACPR, BCIDP, RPh, is with North York General Hospital and the Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario. |
| Source: | The Canadian journal of hospital pharmacy [Can J Hosp Pharm] 2026 Feb 11; Vol. 79 (1), pp. e3823. Date of Electronic Publication: 2026 Feb 11 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Canadian Society of Healthcare-Systems Pharmacy Country of Publication: Canada NLM ID: 0215645 Publication Model: eCollection Cited Medium: Internet ISSN: 1920-2903 (Electronic) Linking ISSN: 00084123 NLM ISO Abbreviation: Can J Hosp Pharm Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1920-2903 |
|---|---|
| DOI: | 10.4212/cjhp.3823 |
